About
Research
Patient Care
Education
Community
April 19, 2023 Bulletin
Events, Announcements & Funding Opportunities
May 3, 2023 Bulletin
May 17, 2023 Bulletin
May 31, 2023 Bulletin
2023 Cancer Center Scientific Retreat
The retreat is open to Cancer Center members, associate members, clinicians, DOT leaders, shared resource teams, community equity board members, established community partners, MET trainees, staff, postdoctoral trainees, and graduate students.
Jung In Park, University of California, Irvine – Survival Machine Learning for Breast Cancer Patients
Racial disparities can exist even in machine learning. Jung In Park, assistant professor in the Sue & Bill Gross School of Nursing at the University of California, Irvine, finds a way to tackle biases and make a difference for vulnerable populations
Shawn Griffin Receives 2023 HOPA Early Career Research Grant
Shawn Griffin, health sciences assistant clinical professor, at the UC Irvine School of Pharmacy & Pharmaceutical Sciences, has received a 2023 Hematology/Oncology Pharmacy Association Early Career Research Grant. The grant will fund a correlative pharmacokinetic study to the ADAPT trial (principal investigator Stefan Ciurea from the UCI School of Medicine) that is about to open at the UCI Chao Family Comprehensive Cancer Center for patients undergoing hematopoietic stem cell transplantation.
Rise in colorectal cancer among young adults an alarming trend
The rise in colon cancer rates among millennials has been alarming. "Physicians are aware, primary care doctors are aware, oncologists are aware, and I am not sure the public is aware that it is a real issue," said Dr. Jason Zell, at UCI Health Chao Family Comprehensive Cancer Center and UCI associate professor.
Chao Lectureship Scientific Lecture: "Targeting Circuits in the Tumor Microenvironment"
The lecture series is named in honor of the Chao family patriarch, the late H. H. Chao and provides a forum to share and discuss topics related to cancer research, prevention and treatment. Each year the lectureship hosts an internationally renowned leader in cancer research, who delivers a technical colloquium in addition to a public lecture. Both lectures are free and open to the public.
UC Irvine study finds that lesbian, gay and bisexual cancer survivors experience more health-related challenges compared to heterosexual counterparts
Public health researchers from the University of California, Irvine have determined that lesbian, gay and bisexual cancer survivors experience a lower quality of life compared to their heterosexual counterparts, specifically in the mental and social aspects of their overall health. Corresponding author Michael Hoyt, PhD, associate professor of population health and disease prevention from UCI’s Program in Public Health, and his collaborators published their findings in the Journal of Psychosocial Oncology.
Adjusting Your Body Clock May Stave Off Cancer
For some time now epidemiological studies of night-shift workers have linked disruptions in circadian rhythms to cancer and other diseases. … “We're starting to understand the reasons these things happen,” says Selma Masri, a circadian biologist and assistant professor at the University of California, Irvine, who has shown how circadian disruption pushes colon cancer progression by interfering with the way certain genes are expressed.
June 14, 2023 Bulletin
UCI Anti-Cancer Challenge hits milestone in search for next breakthrough cancer treatments
Through the unwavering support of dedicated participants, donors and supporters who collectively raised more than $1 million in 2022, the UCI Anti-Cancer Challenge has awarded grants to 28 pilot projects and early phase clinical trials, reaching a remarkable milestone of 100 funded projects since 2017. These projects are poised to revolutionize the future of cancer diagnosis, treatment and cures.
FDA Approves New Drug Combo For Prostate Cancer
Alexandre Chan, PharmD, MPH, professor of clinical pharmacy at the School of Pharmacy & Pharmaceutical Sciences at University of California, Irvine is similarly excited about the prospect of this combination of medications being better understood and implemented. “I think that’s good news for patients, in the sense that there are additional therapies that we can use at first line and [they] have demonstrated that if you have the proper mutations, you get much better progression free and also overall survival.”
The Audley Fund of the Philadelphia Foundation backs Dr. Daniela Bota's search for a glioblastoma cure
UCI Health and neuro-oncologist Dr. Daniela A. Bota, MD are pleased to receive a third consecutive grant from The Audley Fund of the Philadelphia Foundation to support research to find a cure for brain cancer, especially glioblastoma.
Breakthroughs offer hope for vitiligo patients
In 2018, Dr. Anand K. Ganesan (above left) opened a vitiligo specialty practice lab at the UCI Health Beckman Laser Institute & Medical Clinic, hoping to find new therapies to reverse the disfiguring skin disorder. Now, the lab has produced a topical cream called ruxolitinib, the first therapy approved by the U.S. Federal Drug Administration that restores pigment in vitiligo patients. The FDA also recently gave breakthrough device approval for RECELL®, a one-time therapy using the patient’s healthy cells to stimulate lasting repigmentation in stable vitiligo.
UCI Health Named One of America's Best Cancer Hospitals by Newsweek
UCI Health has been recognized as one of America’s Best Cancer Hospitals by Newsweek in its inaugural rankings of the specialty, highlighting our commitment to exceptional cancer care. The UCI Health Chao Family Comprehensive Cancer Center is one of only 53 centers designated as comprehensive by the National Cancer Institute (NCI) and the only one in Orange County. The cancer center offers one of the region’s largest early phase cancer clinical trials programs.
June 28, 2023 Bulletin
Research in Progress Quarterly Seminar - Dr. Christopher Halbrook, PhD
Seminar given by Dr. Christopher Halbrook: Targeting Metabolic Support and Resistance Networks in Pancreatic Cancer
Setting her sights on a future without rectal cancer
After months of pain that was dismissed as hemorrhoids, Claudia Sanchez went to the hospital. “By the time I made it to the ER, I couldn’t even sit,” she explains. The doctor ordered a CT scan. The results brought devastating news: Sanchez had a large rectal tumor.